A carregar...
Calcium blockers decrease the bortezomib resistance in mantle cell lymphoma via manipulation of tissue transglutaminase activities
Although bortezomib is clinically approved for the treatment of mantle cell lymphoma (MCL), only limited effects of this treatment have been demonstrated. To improve survival for bortezomib-resistant patients, it is necessary to develop new therapeutic strategies. In the present study, we used bioch...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Hematology
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3311276/ https://ncbi.nlm.nih.gov/pubmed/22294726 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-09-377598 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|